PROBETA - LIQ OPH
PROBETA - LIQ OPH
Discontinued
DIN Number
02209071
Drug Class
Human
Market Date
Aug 30, 1996
Company
HC
Allergan, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02209071
AIG Number0228436001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01ED53 LEVOBUNOLOL, COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationOphthalmic
AHFS Classification52:40.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
DIPIVEFRIN HYDROCHLORIDEActive
Strength: 0.1 %
Monograph: DIPIVEFRIN HYDROCHLORIDE
LEVOBUNOLOL HYDROCHLORIDEActive
Strength: 0.5 %
Monograph: LEVOBUNOLOL HYDROCHLORIDE